Abstract
Antigen.antibody complexes (Ag.Ab) prepared from (125)I-labeled bovine serum albumin and guinea pig anti-albumin were incubated at 37 degrees C for 30 min with normal human serum diluted optimally for binding (1:16) and then with autologous erythrocytes (RBC). After washing, RBC-bearing antigen.antibody.complement complexes (Ag.Ab.C) were resuspended in serum reagents or solutions of purified complement components, and the kinetics of dissociation were analyzed. Ag.Ab.C dissociated in serum heated at 56 degrees C for 30 min (SDelta30) but not in serum heated for 120 min (SDelta120). Dissociation in SDelta30 markedly decreased after adsorption with anti-C3b inactivator but not anti-beta1H or anti-C4 binding protein (C4bp), and dissociation in SDelta120 markedly increased after addition of C3b inactivator. Hemolytic assays revealed that SDelta30 retained inactivator activity whereas SDelta120 lacked significant activity. Ag.Ab.C dissociated in the presence of purified inactivator or C3b but not beta1H or C3. Dissociation was more rapid with inactivator than with C3b and occurred at 0 degrees C as well as at 37 degrees C. Treatment with inactivator inhibitor abolished dissociation in SDelta30; dissociation in inactivator deficient serum was markedly reduced. Addition of beta1H did not enhance inactivator-mediated dissociation at limiting dilutions of inactivator, and adsorption of Ag.Ab.C with anti-beta1H or preparation of Ag.Ab.C with serum adsorbed with anti-beta1H did not diminish dissociation. After dissociation with inactivator, Ag.Ab.C were unchanged in size but were no longer able to bind to fresh RBC and gave enhanced binding to Raji and Daudi lymphoblastoid cells. NaDodSO(4)/polyacrylamide gel electrophoresis of Ag.Ab.C prepared with (125)I-labeled C3 revealed that, after binding to RBC, dissociation with inactivator was accompanied by generation of a C3 fragment the size of C3c. Preincubation of Ag.Ab.C with excess inactivator did not prevent subsequent binding of Ag.Ab.C to RBC but, immediately after binding, Ag.Ab.C dissociated rapidly. These findings indicate that C3b inactivator can release immune complexes from immune adherence receptors on human RBC, that release occurs independently of beta1H, alters cell binding properties of immune complexes, and involves multiple cleavages of the C3b alpha' chain, and that receptors in human RBC membrane are required for this C3b inactivator-mediated breakdown.
MeSH Terms
Antigen-Antibody Complex
Complement C3/immunology
Complement C3b Inactivator Proteins/immunology
Complement C4/immunology
Complement Factor H
Erythrocyte Membrane/immunology
Erythrocytes/immunology
Protein Binding
Receptors, Immunologic/metabolism
Solubility
Chemicals
Antigen-Antibody Complex
CFH protein, human
Complement C3
Complement C3b Inactivator Proteins
Complement C4
Receptors, Immunologic
Complement Factor H
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Medof M E
Prince G M
Mold C
References (24)
24 references, click to expand
-
The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.
J Exp Med. 1966 Jan 1;123(1):33-54
PMID: 4159289
-
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
J Immunol. 1968 Apr;100(4):691-8
PMID: 5645214
-
Immune adherence by the fourth component of complement.
Science. 1969 Jul 25;165(3891):396-8
PMID: 5815256
-
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
J Biol Chem. 1969 Aug 25;244(16):4406-12
PMID: 5806584
-
Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.
J Immunol. 1971 Feb;106(2):304-13
PMID: 5545135
-
C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
J Immunol. 1971 Sep;107(3):742-50
PMID: 4999095
-
Immune adherence by the alternate complement pathway.
Proc Soc Exp Biol Med. 1972 Oct;141(1):287-90
PMID: 4563101
-
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
J Exp Med. 1974 Oct 1;140(4):877-94
PMID: 4139225
-
A new complement function: solubilization of antigen-antibody aggregates.
Proc Natl Acad Sci U S A. 1975 Feb;72(2):418-22
PMID: 1054824
-
Specificity of human lymphocyte complement receptors.
J Exp Med. 1975 May 1;141(5):1163-80
PMID: 805205
-
Studies on the mechanism of solubilization of immune precipitates by serum.
J Exp Med. 1976 Mar 1;143(3):615-30
PMID: 1249522
-
Modulation of the alternative complement pathways by beta 1 H globulin.
J Exp Med. 1976 Nov 2;144(5):1147-63
PMID: 62817
-
Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
J Exp Med. 1977 Jul 1;146(1):257-70
PMID: 301546
-
Evidence that bovine conglutinin reacts with an early product of C3b degradation, and an improved conglutination assay.
J Immunol. 1978 Aug;121(2):658-64
PMID: 98586
-
Mechanism of action of factor D of the alternative complement pathway.
J Exp Med. 1978 Dec 1;148(6):1498-509
PMID: 82604
-
Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71
PMID: 293688
-
Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600
PMID: 293746
-
Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
J Immunol. 1981 Jul;127(1):104-8
PMID: 7240739
-
Complement receptor is an inhibitor of the complement cascade.
J Exp Med. 1981 May 1;153(5):1138-50
PMID: 6910481
-
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
J Exp Med. 1981 Sep 1;154(3):856-67
PMID: 6912277
-
C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
Biosci Rep. 1981 Nov;1(11):873-80
PMID: 6458338
-
Competition for immune complexes by red cells in human blood.
J Clin Lab Immunol. 1982 Jan;7(1):7-13
PMID: 7069779
-
Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
Clin Exp Immunol. 1982 Jun;48(3):715-25
PMID: 7116690
-
The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.
Science. 1953 Dec 18;118(3077):733-7
PMID: 13122009